The Democratic presidential candidate, Sen.Bernie Sanders, speaks to the media after boarding the plane at the Des Moines International Airport on February 4, 2020. The results from the Iowa caucus are expected to be released on February 11 and Mr. Sanders was going to New Hampshire to campaign before the primary on February 11.
Joe Raedle is a photographer.
The shares of Moderna and BioNTech plummeted on Monday after a critical message from Senator Bernie Sanders.
After the Omicron variant was identified, the companies' stock prices went up.
It's time for pharmaceutical companies to control their greed and share their vaccines with the world.
The shares of Moderna and BioNTech plummeted as much as 16% and 20%, respectively, on Monday, after Vermont Senator Bernie sanders criticized them on his verified account.
The surge in the companies' stock prices came after a new variant of COVID-19 was identified. Moderna's shares soared as much as 35% after the Omicron news, while BioNTech's shares jumped as much as 19%.
The higher stock prices can be attributed to investors belief that the vaccine makers will have a longer runway ahead as they work to eradicate the COVID-19 pandemic. Fears of Omicron have helped drive a surge in booster shots and new vaccinations in recent weeks.
The companies and their investors have made a lot of money, but the companies should share it with the rest of the world.
This is offensive. The news about the Omicron variant spread made 8 investors in Pfizer and Moderna $10 billion richer. It's time for the pharmaceutical companies to control their greed and share their vaccines with the world. Enough is enough! Sunday evening, he wrote.
The stock prices of the drugmakers plummeted on Monday, after a growing number of anecdotal evidence that Omicron is less deadly than prior versions. On Monday, Pfizer fell as much as 5%.
Moderna and Pfizer have made their vaccines available to countries other than the US, despite the fact that poorer nations are near the end of the vaccine line as the vaccine makers focus on generating profits by selling the vaccines to richer countries for a higher price.
All of the gains were wiped out by the decline on Monday and some since the news of the Omicron variant was announced. Since the Thanksgiving holiday in late November, BioNTech and Moderna have both fallen by 8% and 5%.
Koyfin.
Business Insider has an original article.
